Merck announces it has agreed to purchase two biotechnology firms that will help it discover and produce products.Merck Merck may refer to:
Santa Clara (sän`tä klä`rä), city (1994 est. pop. 217,000), capital of Villa Clara prov., central Cuba. , CA, for $80 million. GlycoFi has developed a yeast-based, proprietary technology to develop proteins to treat or prevent diseases. Merck says the technology can result in higher yields and faster development of products than traditional methods for making biologics in mammalian mammalian emanating from or pertaining to mammals. cell cultures. Abmaxis has a technology to assist with the identification of proteins known as monoclonal antibodies This is a list of monoclonal antibodies, antibodies which are clones of a single parent cell. When used as medications, the generic names end in -mab (see "Nomenclature of monoclonal antibodies"). that can serve as the basis for biologic products. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion